BMJ 1998;316:1771-1775 ( 13 June )

Papers

Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study

Ravi Mahadeva, Anglia and Oxford research fellowa Kevin Webb, consultant physicianb Roger C Westerbeek, biostatisticianc Nick R Carroll, senior registrard Mary E Dodd, senior physiotherapistb Diana Bilton, consultant physiciane David A Lomas, honorary consultant physiciana

a Department of Haematology, University of Cambridge, Medical Research Council Centre, Cambridge CB2 2QH, b Bradbury Cystic Fibrosis Unit, Wythenshawe Hospital NHS Trust, Manchester M23 9LT, c Medical Research Council Biostatistics Unit, University of Cambridge CB2 2QQ, d Addenbrooke's Hospital NHS Trust, Cambridge CB2 2QQ, e Cystic Fibrosis Unit, Papworth Hospital NHS Trust, Papworth Everard, Cambridge CB3 8RE

Correspondence to: Dr Bilton

Objectives: To assess the effect on clinical outcome of managing paediatric and adult patients with cystic fibrosis at specialised cystic fibrosis centres.
Design: Cross sectional study.
Setting: Two adult cystic fibrosis centres in the United Kingdom.
Subjects: Patients from an adult cystic fibrosis centre in Manchester were subdivided into those who had received continuous care from paediatric and adult cystic fibrosis centres (group A), and those who had received paediatric care in a centre not specialising in cystic fibrosis followed by adult care in a cystic fibrosis centre (group B). Group C were referrals to the new adult cystic fibrosis centre in Cambridge who had received neither paediatric nor adult centre care for their cystic fibrosis.
Main outcome measures: Body mass index (weight (kg)/height (m2)), lung function (forced expiratory volume in one second (FEV1 percentage of predicted)), the Northern chest x ray film score, and age at colonisation with Pseudomonas aeruginosa.
Results: A prominent stepwise increase in body mass index was associated with increasing amounts of care at a cystic fibrosis centre; 18.3, 20.2, and 21.3 for groups C, B, and A respectively (P<0.001). Improved nutritional status was correlated with a higher FEV1 and better (lower) chest x ray film scores; r=0.52 and -0.45 respectively (P<0.001 for both).
Conclusion: These findings provide the first direct evidence that management of cystic fibrosis in paediatric and adult cystic fibrosis centres results in a better clinical outcome, and strongly supports the provision of these specialist services.

Key messages

  • Management of patients with cystic fibrosis in paediatric and adult cystic fibrosis centres results in an improved clinical outcome

  • Improved clinical outcome occurred in cystic fibrosis centres despite earlier and more frequent colonisation with Pseudomonas aeruginosa

  • Nutritional status is an important predictor of lung disease in cystic fibrosis



© BMJ 1998

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Clinical outcome in relation to care in centres specialising in cystic fibrosis
David Spencer and D Bilton
BMJ 1999 318: 58. [Extract] [Full Text]

Adults with cystic fibrosis need specialist care
Jenny Bryan
BMJ 1998 316: 1929. [Extract] [Full Text]

Precise measurement and poetry
BMJ 1998 316: 0. [Full Text]

Centre care of cystic fibrosis improves clinical outcome
BMJ 1998 316: 0. [Full Text]

This article has been cited by other articles:

  • Hill, M, Ben-Shlomo, Y (2008). Neurological care and risk of hospital mortality for patients with myasthenia gravis in England. J. Neurol. Neurosurg. Psychiatry 79: 421-425 [Abstract] [Full text]  
  • Stern, M., Wiedemann, B., Wenzlaff, P., on behalf of the German Cystic Fibrosis Quality As, (2008). From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995 2006. Eur Respir J 31: 29-35 [Abstract] [Full text]  
  • Balfour-Lynn, I. M (2008). Newborn screening for cystic fibrosis: evidence for benefit. Arch. Dis. Child. 93: 7-10 [Full text]  
  • Bell, S. C, Robinson, P. J (2007). Exacerbations in cystic fibrosis: 2 {middle dot} Prevention. Thorax 62: 723-732 [Abstract] [Full text]  
  • Slieker, M. G., Uiterwaal, C. S. P. M., Sinaasappel, M., Heijerman, H. G. M., van der Laag, J., van der Ent, C. K. (2005). Birth Prevalence and Survival in Cystic Fibrosis: A National Cohort Study in the Netherlands. Chest 128: 2309-2315 [Abstract] [Full text]  
  • Durairaj, L., Torner, J. C., Chrischilles, E. A., Vaughan Sarrazin, M. S., Yankey, J., Rosenthal, G. E. (2005). Hospital Volume-Outcome Relationships Among Medical Admissions to ICUs. Chest 128: 1682-1689 [Abstract] [Full text]  
  • Parmar, J S, Nasser, S (2005). Antibiotic allergy in cystic fibrosis. Thorax 60: 517-520 [Abstract] [Full text]  
  • Moorcroft, A J, Dodd, M E, Morris, J, Webb, A K (2004). Individualised unsupervised exercise training in adults with cystic fibrosis: a 1 year randomised controlled trial. Thorax 59: 1074-1080 [Abstract] [Full text]  
  • Sawczenko, A, Lynn, R, Sandhu, B K (2003). Variations in initial assessment and management of inflammatory bowel disease across Great Britain and Ireland. Arch. Dis. Child. 88: 990-994 [Abstract] [Full text]  
  • Jones, A M, Govan, J R W, Doherty, C J, Dodd, M E, Isalska, B J, Stanbridge, T N, Webb, A K (2003). Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak. Thorax 58: 525-527 [Abstract] [Full text]  
  • Wat, D (2003). Impact of respiratory viral infections on cystic fibrosis. Postgrad. Med. J. 79: 201-203 [Abstract] [Full text]  
  • Armstrong, D. S., Nixon, G. M., Carzino, R., Bigham, A., Carlin, J. B., Robins-Browne, R. M., Grimwood, K. (2002). Detection of a Widespread Clone of Pseudomonas aeruginosa in a Pediatric Cystic Fibrosis Clinic. Am. J. Respir. Crit. Care Med. 166: 983-987 [Abstract] [Full text]  
  • Cropper, S, Hopper, A, Spencer, S A, Dodd, K (2002). Managed clinical networks. Arch. Dis. Child. 87: 1-4 [Full text]  
  • Ledson, M J, Gallagher, M J, Jackson, M, Hart, C A, Walshaw, M J (2002). Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax 57: 142-145 [Abstract] [Full text]  
  • STALLARD, K, SEALE, H, BELL, S C (2001). Cost of physiotherapy in CF. Thorax 56: 980a-980 [Full text]  
  • Josserand, R. N., Bey-Omar, F., Rollet, J., Lejeune, H., Boggio, D., Durand, D. V., Durieu, I. (2001). Cystic fibrosis phenotype evaluation and paternity outcome in 50 males with congenital bilateral absence of vas deferens. Hum Reprod 16: 2093-2097 [Abstract] [Full text]  
  • Doull, I. J M (2001). Recent advances: Recent advances in cystic fibrosis. Arch. Dis. Child. 85: 62-66 [Abstract] [Full text]  
  • Wiedemann, B., Steinkamp, G., Sens, B., Stern, M. (2001). The German cystic fibrosis quality assurance project: clinical features in children and adults. Eur Respir J 17: 1187-1194 [Abstract] [Full text]  
  • DA SILVA FILHO, L. V. F., LEVI, J. E., BENTO, C. N. O., RODRIGUES, J. C., DA SILVA RAMOS, S. R. T. (2001). Molecular epidemiology of Pseudomonas aeruginosa infections in a cystic fibrosis outpatient clinic. J Med Microbiol 50: 261-267 [Abstract] [Full text]  
  • Robinson, P (2001). Paediatric origins of adult lung disease {bullet} 7: Cystic fibrosis. Thorax 56: 237-241 [Full text]  
  • Jones, A.M., Dodd, M.E., Webb, A.K. (2001). Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas. Eur Respir J 17: 295-301 [Abstract] [Full text]  
  • Mitchell, I., Nakielna, E., Tullis, E., Adair, C. (2000). Cystic Fibrosis : End-Stage Care in Canada. Chest 118: 80-84 [Abstract] [Full text]  
  • Fogarty, A., Hubbard, R., Britton, J. (2000). International Comparison of Median Age at Death From Cystic Fibrosis. Chest 117: 1656-1660 [Abstract] [Full text]  
  • MAHADEVA, R., LOMAS, D. A (2000). Secondary genetic factors in cystic fibrosis lung disease. Thorax 55: 446-446 [Full text]  
  • Collins, C. E, MacDonald-Wicks, L., Rowe, S., O'Loughlin, E. V, Henry, R. L (1999). Normal growth in cystic fibrosis associated with a specialised centre. Arch. Dis. Child. 81: 241-246 [Abstract] [Full text]  
  • Jaffé, A, Bush, A, Geddes, D M, Alton, E W F W (1999). Prospects for gene therapy in cystic fibrosis. Arch. Dis. Child. 80: 286-289 [Full text]  
  • Spencer, D., Bilton, D (1999). Clinical outcome in relation to care in centres specialising in cystic fibrosis. BMJ 318: 58a-58 [Full text]  

Rapid Responses:

Read all Rapid Responses

Conflict of interest in an conclusions on the best place for Cystic Fibrosis Care
R D Barker
bmj.com, 25 Sep 1998 [Full text]



Student BMJ

Sepsis

The latest guidlines will affect how we practice medicine

www.student.bmj.com

Listen to the latest BMJ Interview